Good questions. Clearer answers.
Explore medical weight loss, hormones, men’s health, and everyday wellbeing. Find a topic, read at your pace, and bring your questions to us.
Menopausal Hormone Therapy Label Changes: What the FDA Update Means
Learn what the FDA’s menopausal hormone therapy label update changes, what it does not establish, and what to ask a licensed clinician.
Read the story
Beyond Weight Change: Questions About New Obesity Medicines
Learn how to discuss goals beyond weight change, interpret obesity-medicine research carefully, and prepare questions for a clinical consultation.
Read the storyTestosterone After Menopause: Evidence Gaps and Questions
Explore questions about testosterone use after menopause, evidence uncertainties, and how to discuss options with a licensed clinician.
Read the story2026: Questions About Lifestyle Support and Weight Medication
Prepare for a weight-management consultation with questions about goals, lifestyle support, medication discussions, and follow-up.
Read the storySupplement Research and Weight Management: What Can a Study Show?
Learn how to evaluate supplement research and weight-loss claims, what a study of another health measure can establish, and what Atlanta adults can ask a clinician.
Read the storySarcopenic Obesity During Menopause: What a Cohort Study Can—and Cannot—Tell You
Learn what sarcopenic obesity means, what a Korean cohort observed across menopause stages, and why observational findings cannot predict an individual’s body composition or prove cause.
Read the storyWhat Early Oral Semaglutide Uptake Data Can—and Can’t—Tell Atlanta Adults
Learn what medication uptake data can and cannot establish about oral semaglutide and obesity, and which questions Atlanta adults can bring to a physician discussion.
Read the storyGLP‑1s and Knee Osteoarthritis: How 2026 Evidence Can Inform Atlanta Care Conversations
How 2026 evidence and ACR’s conditional update on GLP‑1s relate to knee osteoarthritis and physician‑supervised weight management in Atlanta. Safety, expectations, and visit questions—without assuming an individual outcome.
Read the story
Low T Evaluation in Atlanta: When Calculated Free Testosterone Matters in Obesity or Diabetes
In Atlanta, men with obesity or diabetes may benefit from calculated free testosterone in low T evaluations because SHBG can alter total levels. Learn why morning, repeat testing and assay quality matter, and which clinic-visit questions to ask without assuming outcomes.
Read the story
After the 2026 Endocrine Society Statement: Pairing Lifestyle and Medications in Atlanta
After the Endocrine Society’s 2026 statement, learn which clinic‑visit questions and monitoring topics help Atlanta adults combine lifestyle strategies with physician‑supervised weight‑management medications, grounded in FDA labeling and evolving evidence.
Read the storyFDA’s 2026 HRT Label Changes: What to Discuss at a Menopause Visit in Atlanta
What Atlanta adults should know about the FDA’s 2026 menopause hormone therapy labeling changes, how risks and benefits are now framed, and evidence-based questions to discuss with a clinician.
Read the storyMenopause and Midlife Weight in Atlanta: Exercise, Waist, and Diet Evidence for Better Clinic Visits
Atlanta-focused explainer on exercise, waist circumference, and diet at midlife. See what research shows, how obesity-care standards use waist measures, and which clinic-visit questions help personalize care without assuming outcomes.
Read the story